መነሻ › ሉኬሚያ › Tennessee › Nashville
በNashville፣ TN ለሉኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች
ለሉኬሚያ የሚደረጉ 12 ጥናቶች በNashville እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Quetzal Site 12, Nashville
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Sarah Cannon Research Institute, Nashville
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Tennessee Oncology, Nashville
- TriStar Centennial Medical Center, Nashville
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Vanderbilt University Medical Center, Nashville
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- TriStar BMT, Nashville
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Vanderbilt University, Ingram Cancer Center, Nashville
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Vanderbilt University Medical Center, Nashville
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
ተሳታዮችን በመፈለግ ላይደረጃ 1
- TriStar Bone Marrow Transplant, Nashville
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- Vanderbilt-Ingram Cancer Center, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massive Bio SYNERGY-AI site, Nashville
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Sarah Cannon Research Institute, Nashville
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
- TriStar Bone Marrow Transplant, Nashville
በሌሎች ከተሞች ለሉኬሚያ የሚደረጉ ጥናቶች
- Houston, TX28 ጥናቶች
- Boston, MA25 ጥናቶች
- New York City, NY19 ጥናቶች
- Los Angeles, CA16 ጥናቶች
- Chicago, IL16 ጥናቶች
- Durham, NC13 ጥናቶች
- Columbus, OH12 ጥናቶች
- Baldwin Park, CA12 ጥናቶች
- Philadelphia, PA12 ጥናቶች
- Milwaukee, WI11 ጥናቶች
- Atlanta, GA11 ጥናቶች
- Seattle, WA11 ጥናቶች
በNashville ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር97 ጥናቶች
- የጡንቻ ካንሰር80 ጥናቶች
- Metastatic Cancer70 ጥናቶች
- የኮሎሬክታል ካንሰር69 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)65 ጥናቶች
- የእንቁላል ካንሰር49 ጥናቶች
- የፕሮስቴት ካንሰር42 ጥናቶች
- የሳንባ ካንሰር40 ጥናቶች
- የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ39 ጥናቶች
- የፓንክሪያስ ካንሰር39 ጥናቶች
- የኤንዶሜትሪየም ካንሰር38 ጥናቶች
- ሜላኖማ33 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።